Patrick Plewman, the SVP for Diagnostic Services of $DGX, sold 3,560 shares of the company on 08-06-2025 for an estimated $623,000. We received data on the trade from a recent SEC filing. This was a sale of approximately 14.4% of their shares of this class of stock. Following this trade, they now own 21,185 shares of this class of $DGX stock.
$DGX Insider Trading Activity
$DGX insiders have traded $DGX stock on the open market 33 times in the past 6 months. Of those trades, 0 have been purchases and 33 have been sales.
Here’s a breakdown of recent trading of $DGX stock by insiders over the last 6 months:
- J. E. DAVIS (CEO and President) has made 0 purchases and 15 sales selling 39,191 shares for an estimated $6,602,074.
- KARTHIK KUPPUSAMY (SVP, Clinical Solutions) has made 0 purchases and 4 sales selling 13,034 shares for an estimated $2,194,280.
- CATHERINE T. DOHERTY (EVP, Regional Businesses) has made 0 purchases and 5 sales selling 8,344 shares for an estimated $1,447,689.
- MICHAEL E PREVOZNIK (SVP & General Counsel) has made 0 purchases and 4 sales selling 6,367 shares for an estimated $1,087,793.
- PATRICK PLEWMAN (SVP for Diagnostic Services) has made 0 purchases and 3 sales selling 5,855 shares for an estimated $1,022,932.
- MARK E DELANEY (SVP & Chief Commercial Officer) has made 0 purchases and 2 sales selling 1,748 shares for an estimated $306,800.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$DGX Hedge Fund Activity
We have seen 443 institutional investors add shares of $DGX stock to their portfolio, and 437 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO added 1,336,025 shares (+54.9%) to their portfolio in Q1 2025, for an estimated $226,055,429
- DAVIS SELECTED ADVISERS removed 1,033,882 shares (-43.3%) from their portfolio in Q2 2025, for an estimated $185,716,223
- NORDEA INVESTMENT MANAGEMENT AB removed 1,029,219 shares (-81.9%) from their portfolio in Q2 2025, for an estimated $184,878,608
- M&G PLC added 771,824 shares (+256.5%) to their portfolio in Q2 2025, for an estimated $138,642,745
- BOSTON PARTNERS added 739,407 shares (+32.2%) to their portfolio in Q2 2025, for an estimated $132,819,679
- MILLENNIUM MANAGEMENT LLC removed 638,498 shares (-97.7%) from their portfolio in Q1 2025, for an estimated $108,033,861
- NEUBERGER BERMAN GROUP LLC added 570,785 shares (+868.3%) to their portfolio in Q1 2025, for an estimated $96,576,822
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$DGX Congressional Stock Trading
Members of Congress have traded $DGX stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $DGX stock by members of Congress over the last 6 months:
- REPRESENTATIVE CAROL D. MILLER sold up to $15,000 on 03/10.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$DGX Analyst Ratings
Wall Street analysts have issued reports on $DGX in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Baird issued a "Outperform" rating on 04/23/2025
- Mizuho issued a "Outperform" rating on 04/09/2025
- Redburn Atlantic issued a "Buy" rating on 04/02/2025
To track analyst ratings and price targets for $DGX, check out Quiver Quantitative's $DGX forecast page.
$DGX Price Targets
Multiple analysts have issued price targets for $DGX recently. We have seen 11 analysts offer price targets for $DGX in the last 6 months, with a median target of $189.0.
Here are some recent targets:
- David Macdonald from Truist Securities set a target price of $192.0 on 07/23/2025
- Pito Chickering from Deutsche Bank set a target price of $178.0 on 07/23/2025
- Kevin Caliendo from UBS set a target price of $180.0 on 07/23/2025
- Lisa Gill from JP Morgan set a target price of $190.0 on 05/06/2025
- David Westenberg from Piper Sandler set a target price of $200.0 on 04/28/2025
- Stephanie Davis from Barclays set a target price of $185.0 on 04/23/2025
- Elizabeth Anderson from Evercore ISI Group set a target price of $180.0 on 04/23/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
